|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
EBSCO_ocn874173821 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
140222t20122012fr a ob 000 0 fre d |
040 |
|
|
|a E7B
|b eng
|e rda
|e pn
|c E7B
|d OCLCO
|d N$T
|d OCLCF
|d YDXCP
|d EBLCP
|d OCLCQ
|d VT2
|d OCLCO
|d QGK
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 903207225
|a 923189363
|a 1259062990
|
020 |
|
|
|a 9782742012688
|q (electronic bk.)
|
020 |
|
|
|a 2742012680
|q (electronic bk.)
|
020 |
|
|
|z 9782742007660
|
029 |
1 |
|
|a AU@
|b 000067007228
|
029 |
1 |
|
|a DEBBG
|b BV043027061
|
029 |
1 |
|
|a DEBSZ
|b 446420735
|
029 |
1 |
|
|a DKDLA
|b 820120-katalog:999941793405765
|
035 |
|
|
|a (OCoLC)874173821
|z (OCoLC)903207225
|z (OCoLC)923189363
|z (OCoLC)1259062990
|
050 |
|
4 |
|a RC270.8
|b .C535 2012eb
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.99406
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
4 |
|a Les cibles nucléaires en oncologie /
|c coordonné par Jacques Robert et Éric Raymond.
|
250 |
|
|
|a Une édition conjointe.
|
264 |
|
1 |
|a Montrouge, France :
|b John Libbey Eurotext,
|c 2012.
|
264 |
|
4 |
|c ©2012
|
300 |
|
|
|a 1 online resource (123 pages) :
|b illustrations (some color), tables
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Thérapie ciblée des cancers / Application médicale du gène ;
|v v. 7
|
504 |
|
|
|a Includes bibliographical references.
|
588 |
0 |
|
|a Online resource; title from PDF title page (ebrary, viewed February 21, 2014).
|
505 |
0 |
|
|a ""Les cibles nucléaires en oncologie""; ""Sommaire""; ""Préface""; ""Les cibles nucléaires : g�nes, transcrits et protéines""; ""Les inhibiteurs de PARP : du laboratoire au lit du patient""; ""Le ciblage de la télomérase et des télom�res""; ""Le ciblage des kinases cycline-dépendantes (CDK) et des kinases mitotiques Aurora et Polo-like""; ""Le ciblage de l�interaction MDM2�p53""; ""La méthylation de l�ADN""; ""Le ciblage des histone sdésacétylases""; ""Les thérapies géniques""
|
546 |
|
|
|a French.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Cancer
|x Treatment.
|
650 |
|
0 |
|a Cytoplasm.
|
650 |
|
0 |
|a Tumors.
|
650 |
|
2 |
|a Cytoplasm
|
650 |
|
2 |
|a Neoplasms
|
650 |
|
6 |
|a Cancer
|x Traitement.
|
650 |
|
6 |
|a Cytoplasme.
|
650 |
|
6 |
|a Tumeurs.
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Cancer
|x Treatment
|2 fast
|
650 |
|
7 |
|a Cytoplasm
|2 fast
|
650 |
|
7 |
|a Tumors
|2 fast
|
700 |
1 |
|
|a Robert, Jacques.
|
700 |
1 |
|
|a Raymond, Eric.
|
776 |
0 |
8 |
|i Print version:
|t Cibles nucléaires en oncologie.
|b Une édition conjointe.
|d Montrouge, France : John Libbey Eurotext, ©2012
|h ix, 109 pages
|k Thérapie Ciblée Des Cancers ; 7
|x 1775-5565
|z 9782742007660
|
830 |
|
0 |
|a Thérapie ciblée des cancers / Application médicale du gène.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=779079
|z Texto completo
|
936 |
|
|
|a BATCHLOAD
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3317995
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10836941
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 779079
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 11655572
|
994 |
|
|
|a 92
|b IZTAP
|